9 Procurement Questions to Test a Medical Supply

Procurement team comparing supplier substitution responses

When an ordered item is out of stock, a proper substitution policy means the supplier notifies you before shipping a replacement, documents the manufacturer and lot details of the new item, holds pricing steady or issues a credit for any difference, and accepts a return if the substitute does not meet your needs. Anything less than that combination leaves your facility exposed to compliance gaps and unplanned costs. Some suppliers outline substitution practices for procurement teams who ask before placing large or recurring orders.

TL;DR:

Suppliers should notify you of out-of-stock items and propose substitutes before shipment, providing manufacturer, UDI-DI, and lot documentation for each change.
Pricing on substitutes must remain consistent with original items, with credits issued for any difference, and return costs clearly outlined if the substitute is unacceptable.
Automatic approval applies only to low-risk consumables with pre-vetted lists; clinically used items require explicit sign-off by responsible staff.
Repeated substitutions or undisclosed material changes are red flags, potentially triggering regulatory scrutiny or order holds.
Testing a supplier’s policy through direct conversations reveals whether their substitution process is documented, reliable, and suitable for emergency or routine use.

Source Medical Supplies With Confidence

Browse medical products and equipment from Queens Surgical, serving healthcare professionals, clinics, hospitals, and organizations across the Americas.

Browse medical supplies

Core elements every substitution policy should state
How to evaluate a supplier’s substitution policy: a procurement checklist
What happens to an order when an item is out of stock
Red flags, regulatory touchpoints, and when to escalate
How Queens Surgical approaches substitutions
If you need a supplier with a clear substitution approach
Sources
FAQ

Core elements every substitution policy should state

A substitution policy is only useful if it answers specific operational questions before an order ships, not after a nurse opens the box. Vendors that take this seriously put these elements in writing rather than leaving them to a phone call with a sales rep.

Notification timing: the supplier should flag an out-of-stock item and propose an alternative within a reasonable window, ideally before the order leaves the warehouse, not after delivery.
Approval model: low-risk consumables might qualify for auto-approval against a pre-vetted list, while anything used in a procedure typically needs an explicit sign-off from the ordering staff or a clinical reviewer.
Pricing terms: the replacement should carry the same price as the original item, or the supplier should issue a credit for any difference rather than billing at a higher rate.
Documentation: every substitute needs the manufacturer name, catalog number, UDI-DI, lot number, expiration date, and a certificate of conformance when the product category calls for one.
Allocation rules: during regional shortages, suppliers may ration inventory across customers, which can extend lead times even for approved substitutes.
Return and acceptance terms: if a substitute does not work for your setting, the policy should state clearly who covers return shipping and disposal costs.

The FDA recommends that health care providers maintain contingency communication plans with distributors covering availability, allocation limits, and viable alternatives, which puts the burden partly on the buyer to ask these questions up front rather than assume they are covered. Traceability deserves particular attention: our UDI tracking guide walks through the errors that show up in GUDID records when substitution details get logged incorrectly.

How to evaluate a supplier’s substitution policy: a procurement checklist

Reading a policy document is one thing. Testing it against a real conversation with an account rep is what actually reveals how a supplier behaves under pressure.

Ask whether substitutions are communicated by phone, e-mail, or portal alert, and how fast that notice typically arrives.
Ask for the manufacturer, catalog number, and UDI-DI of any proposed substitute before you approve it.
Ask what triggers automatic approval versus a required sign-off from your team.
Ask how price differences are handled: credit, price match, or a request for a change order.
Ask what happens if the substitute arrives and does not meet your specification.
Ask who pays for return shipping or disposal on a rejected substitute.
Ask how often substitutions have occurred on your product lines over the past year.
Ask whether the supplier maintains a pre-vetted substitution list similar to the kind AHRMM recommends for bypassing repeated clinical reviews.
Ask how substitution events get logged for audit purposes.

Score each answer green, amber, or red: green means the policy is documented and specific, amber means the rep gave a verbal answer with no written backup, and red means the question went unanswered. A supplier scoring mostly amber or red on documentation and UDI questions is one to watch closely before committing to a large order.

Pro Tip: Keep a running scorecard across your top five suppliers so a pattern of weak answers shows up before a shortage forces your hand.

What happens to an order when an item is out of stock

A substitution event follows a fairly predictable sequence once you know what to look for, and mapping it out in advance keeps a shortage from turning into a scramble.

The order is placed and the supplier’s system flags the item as out of stock or backordered.
The supplier proposes a substitute along with manufacturer, UDI-DI, and lot documentation.
The order routes to auto-approval for pre-vetted, low-risk consumables, or to a manual approval step for anything used clinically.
The substitute ships, or the original item goes on backorder if no acceptable alternative exists.
Receiving staff inspect the delivery against the documentation provided and either accept the substitute or initiate a return.
The substitution event gets logged in the facility’s MMIS or ERP system with a reason code, the UDI change, and any notes for future reference.

Emergency items, such as airway or hemorrhage control supplies, generally warrant a pre-approved substitution list so clinical staff are never waiting on a manual sign-off mid-crisis. Routine consumables can tolerate a slower manual review. Our urgent care supply list guide covers how to build that kind of two-tier list for fast-moving items. Logging matters as much as the swap itself: without a reason code and UDI reference attached to the record, nobody can later tell whether a batch of complaints traces back to a single substitution decision.

Red flags, regulatory touchpoints, and when to escalate

Some substitutions are routine. Others should stop an order in its tracks until someone with clinical or regulatory authority signs off.

Undisclosed material or design changes: a supplier who swaps materials without flagging it can trigger the kind of compliance issue that shows up in FDA warning letters when customers were never given the chance to review the change.
Missing manufacturer or UDI/lot data: treat this as an automatic hold. Do not accept a “same product” claim without documented evidence, since unchanged dimensions can still mask a different material inside the packaging.
Repeated substitutions on the same SKU: a pattern like this usually signals supplier instability rather than a one-off shortage.
Allocation without advance notice: this suggests the supplier is prioritizing other accounts and may not flag future shortages reliably.

FDA’s 506J guidance requires manufacturers to notify the agency about interruptions likely to cause a device shortage, and the agency tracks these notifications to assess pressure across the supply chain, according to FDA’s medical device shortage guidance. When a substitute fails any of these checks, pause acceptance and route the item to your clinical engineering or value analysis committee before it reaches a patient.

How Queens Surgical approaches substitutions

Some suppliers build their procurement guidance around extensive experience supplying medical products across broad regions, shaping a practical view of substitution: it should never surprise the buyer. Our blog covers the mechanics of this in more depth, including UDI tracking and return handling for procurement teams who want the documentation habits to match the policy language.

The honest take is that most substitution problems are not caused by bad-faith suppliers. They come from vague policies that nobody tested until a shortage hit. A written policy with specific notification windows, documentation requirements, and return terms protects both sides of the transaction, and any supplier reluctant to put that in writing is telling you something. Ask for the document before you need it, not during a crisis.

— QB

If you need a supplier with a clear substitution approach

Some suppliers work with clinics, hospitals, and individual providers who want a straightforward answer when an item runs short: notification first, documented alternatives second, and a return option if the substitute does not fit. Customer service teams may walk procurement staff through sample UDI and manufacturer documentation before a first order is placed.

Browse the full Queens Surgical catalog across wound care, respiratory, urology, and PPE categories.
Review a sample product page like the Self-Adherent Bandage Non-Woven Fabric to see the level of product detail provided.
Contact accounts directly for a written substitution policy and documentation samples before committing to a standing order.

What to check	Where to look
Notification method and timing	Written policy or account rep response
UDI and lot documentation	Sample product page or invoice
Return and credit terms	Written policy or return guide

For teams evaluating how automation affects approval speed on substitutions, Prior Authorization Automation covers how automated workflows can cut the time between a flagged shortage and an approved replacement.

Sources

This guidance draws on AHRMM’s resiliency framework for pre-vetted substitution lists, its item master substitution metric, and FDA’s supply-chain and 506J shortage guidance.

FAQ

What should a substitution policy for medical supplies include?

A solid policy spells out notification timing, an approval process for clinical versus low-risk items, pricing or credit terms, and documentation requirements including manufacturer name, UDI-DI, and lot number. It should also state who pays for return shipping if the substitute does not work for your setting.

How do I know if a substituted product is safe to accept?

Check that the manufacturer, UDI-DI, and lot information match what your facility requires for traceability, and confirm no material or design change occurred without disclosure. If any of that information is missing, hold the item and route it to clinical or value analysis review before use.

Can a supplier change the price when substituting an item?

A supplier should hold the original price or issue a credit for any difference rather than billing you more for a substitute you did not choose. If pricing terms are not addressed in the written policy, ask for clarification before your next order.

What is a clinically acceptable substitution list?

It is a pre-vetted list of equivalent products that purchasing staff can use without repeated clinical committee approval, a practice AHRMM recommends for speeding procurement during shortages. Facilities typically build these lists for high-turnover consumables and emergency items first.

Does Queens Surgical have a written substitution policy?

Queens Surgical provides substitution and documentation details to procurement teams on request, including manufacturer and UDI information for replacement items. Contact customer service directly for the current written policy before placing a standing order.

9 Procurement Questions to Test a Medical Supply Substitution Policy

Table of Contents